Brief: Piramal Pharma Says US FDA Inspection At Turbhe Facility
18/02/2025 11:33
Feb 18 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* US FDA INSPECTION AT PIRAMAL PHARMA'S FACILITY LOCATED AT
TURBHE
* ON CONCLUSION OF INSPECTION, A FORM-483 WAS ISSUED WITH 6
OBSERVATIONS
Source text: ID:nBSE410CGn
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio